HIMSS Awards Cambridge University Hospitals Stage 6 Status of the International Electronic Medical Record Adoption Model

HIMSS UKHealthcare Information and Management Systems Society has awarded Cambridge University Hospitals (CUH) with Stage 6 of the international Electronic Medical Record Adoption Model (EMRAM). The Healthcare Information and Management Systems Society (HIMSS) is an international organisation dedicated to improving healthcare quality, safety, cost-effectiveness and access, through the best use of IT. It developed an Electronic Medical Record Adoption Model (EMRAM) in 2005, which measures progress and the cumulative capabilities of Electronic Medical Record (EMR) systems within hospitals all over the world. Hospitals that reach Stage 6 (Stage 7 being the highest) have established clear goals for improving safety, minimising errors, and recognising the importance of healthcare IT.

This accreditation, which is the only international standard that recognises the effective use of technology in delivering high quality patient care, was validated following an onsite visit by Healthcare Information and Management Systems Society (HIMSS).

HIMSS inspectors visited CUH to assess the use and adoption of its new Epic electronic patient record (EPR) system, which went live on 26 October 2014 across both of its hospitals - Addenbrooke's and the Rosie. As part of the day-long assessment, inspectors spent time with clinical and administrative staff working in paediatrics, pharmacy, radiology, ICU, the emergency department and medical records, observing the delivery of high quality patient care with the use of a fully integrated EPR.

Effective use of the EPR system was showcased including the delivery of closed loop medication to auto identify the nurse, the patient and the medication; increased patient safety and medication error awareness; and many processes now being paperless due to the implementation of the system.

John Rayner, Director of Professional Development at HIMSS Europe, added: "The distance that the Trust has travelled in such a short period of time really stood out during the site visit. To be awarded a Stage 6 validation in less than 12 months of being live with the new system is quite commendable and a real credit to all concerned. We look forward to working with the trust in the future and will observe their progress with considerable interest."

About HIMSS Analytics in Europe
HIMSS Analytics in Europe provides healthcare organisations, governments and industry with extensive data resources and services about the adoption and use of healthcare IT in Europe. HIMSS Analytics' offerings include database and advisory solutions which encompass market research, IT adoption benchmarking, IT Maturity Models for topics like Electronic Medical Records or Continuity of Care. These offerings are designed to support Management and CIOs, IT Executives and Clinicians from across Europe to compare and measure their progress.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...